Arcutis Biotherapeutics, Inc.
ARQT· Nasdaq
ARQTArcutis Biotherapeutics, Inc.
Filed May 12, 2020 · 10-Q · 42 days after period end · 0001787306-20-000010
| Metric | Q1 2020 | Q1 2019 |
|---|---|---|
| Net Income | -$28.01M | -$6.66M |
| EPS Diluted | -$1.15 | -$4.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Arcutis Biotherapeutics, Inc. · CIK 1787306 · Engraved from SEC EDGAR
ended Mar 31, 2020 · filed May 12, 2020 · 42 d after period end
